1433. Factors Associated with Unsuccessful Treatment Outcomes among Patients with Rifampicin Resistant Tuberculosis - Tajikistan, 2015-2020

BACKGROUND: Tajikistan has a high burden of multidrug resistant TB, including rifampicin-resistant TB (RR-TB). Treatment options are more limited and include standard treatment (T1), bedaquiline/delamanid contained individual treatment (T2), short treatment (T3), modified short treatment (T4), and b...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilloeva, Zulfiya Haybullo, Sijotkhonov, Amidkhan S, Zikriyarova, Sanam, Pirmahmadzoda, Bobochon, Alaverdyan, Sevak, Nabirova, Dilyara, Horth, Roberta, Dzhafarov, Navruz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753006/
http://dx.doi.org/10.1093/ofid/ofac492.1262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753006/
http://dx.doi.org/10.1093/ofid/ofac492.1262

Ejemplares similares